The High-Flux research reactor owned by the European Union and managed by NRG at Petten in the Netherlands hit record production in May and was able to continue to provide 30,000 patients daily with medical isotopes.
We use cookies for analytics and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site. To find out more, including how to change your settings, see our Cookie Policy
By David Dalton
11 June 2020